Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Brunswick
BC
$5.28B
| $3.32M | ﹤0.01% |
42,002
-10,052
| -19% | -$828K |
|
|
ITCI
1552
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.32M | ﹤0.01% |
63,688
+21,643
| +51% | +$1.26M |
|
1553
Geron
GERN
$949M
| $3.32M | ﹤0.01% |
1,564,349
+811,192
| +108% | +$2.2M |
|
|
ICPT
1554
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.31M | ﹤0.01% |
178,438
-35,815
| -17% | -$405K |
|
1555
Kirby Corp
KEX
$6.93B
| $3.3M | ﹤0.01% |
39,806
+9,057
| +29% | +$732K |
|
1556
Cathay General Bancorp
CATY
$4.24B
| $3.29M | ﹤0.01% |
94,676
-20,623
| -18% | -$736K |
|
1557
Cabot Corp
CBT
$4.52B
| $3.28M | ﹤0.01% |
47,281
-26,422
| -36% | -$1.84M |
|
1558
Flowers Foods
FLO
$1.57B
| $3.27M | ﹤0.01% |
147,248
+18,610
| +14% | +$446K |
|
1559
Synaptics
SYNA
$4.15B
| $3.27M | ﹤0.01% |
36,511
-116,349
| -76% | -$10.2M |
|
1560
CALL
Tenet Healthcare
THC
$21.1B
| $3.25M | ﹤0.01% |
+49,400
| New | +$3.69M |
|
1561
OGE Energy
OGE
$9.71B
| $3.25M | ﹤0.01% |
97,597
-94,321
| -49% | -$3.3M |
|
1562
WaFd
WAFD
$2.75B
| $3.24M | ﹤0.01% |
126,303
-35,832
| -22% | -$1M |
|
1563
Americold
COLD
$4.27B
| $3.23M | ﹤0.01% |
106,296
+29,052
| +38% | +$939K |
|
1564
CALL
Blackrock
BLK
$176B
| $3.23M | ﹤0.01% |
+5,000
| New | +$3.49M |
|
1565
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $3.22M | ﹤0.01% |
146,735
-44,784
| -23% | -$1.05M |
|
1566
Andersons Inc
ANDE
$2.22B
| $3.22M | ﹤0.01% |
62,506
-14,989
| -19% | -$751K |
|
1567
Affiliated Managers Group
AMG
$9.76B
| $3.22M | ﹤0.01% |
24,674
-4,403
| -15% | -$616K |
|
|
BRSL
1568
Brightstar Lottery PLC
BRSL
$2.03B
| $3.21M | ﹤0.01% |
105,878
+21,029
| +25% | +$670K |
|
1569
Visteon
VC
$2.78B
| $3.2M | ﹤0.01% |
23,202
-4,528
| -16% | -$652K |
|
1570
VanEck Oil Services ETF
OIH
$1.92B
| $3.2M | ﹤0.01% |
9,265
-1,205
| -12% | -$407K |
|
1571
PTC Therapeutics
PTCT
$6.12B
| $3.2M | ﹤0.01% |
142,650
+30,435
| +27% | +$1.13M |
|
|
CERE
1572
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $3.19M | ﹤0.01% |
145,910
+14,568
| +11% | +$365K |
|
|
PINC
1573
DELISTED
Premier
PINC
| $3.18M | ﹤0.01% |
148,136
+58,182
| +65% | +$1.45M |
|
1574
Copa Holdings
CPA
$5.8B
| $3.18M | ﹤0.01% |
35,724
-166,565
| -82% | -$17.3M |
|
1575
DoubleVerify
DV
$2.03B
| $3.17M | ﹤0.01% |
113,593
-320,105
| -74% | -$10.9M |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.